AstraZeneca: Partners and Investors

7 investors · 5 with verified email

AstraZeneca has 7 investors on VCSift, 5 with a verified email address. Roles include Executive Vice President, BioPharmaceuticals R&D and SVP and Head of Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM). The team invests at Seed stage. Sector focus: Pharmaceutical and Pharmaceuticals. Based in United States.

7 investors

Investors and partners at AstraZeneca

JB

Josef Bookert

AstraZeneca

Angel Investor
Seed Pharmaceutical Pharmaceuticals
BM

Brian Murphy

AstraZeneca

Angel Investor
Seed Pharmaceutical Pharmaceuticals
LM

Larry Miller

AstraZeneca

Angel Investor
Seed Pharmaceutical Pharmaceuticals
MS

Mark Stacey

AstraZeneca

Angel Investor
Seed Pharmaceutical Pharmaceuticals
AK

Al Kohlmann

AstraZeneca

Angel Investor
Seed Pharmaceutical Pharmaceuticals
RF

Regina Fritsche-Danielson

SVP and Head of Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM) · AstraZeneca

VC Firm
SB

Sharon Barr

Executive Vice President, BioPharmaceuticals R&D · AstraZeneca

US Angel Investor

How to pitch AstraZeneca

  • Match the stage. Most AstraZeneca investors on VCSift are tagged Seed. A round outside that range is usually a pass before the deck is opened.
  • Lead with the sector fit. The team's tagged focus is Pharmaceutical and Pharmaceuticals. Name the thesis overlap in the first two lines of the email.
  • Pick the right person. Titles on the team include Executive Vice President, BioPharmaceuticals R&D and SVP and Head of Research and Early Development, Cardiovascular, Renal and Metabolism (CVRM). Partners and principals source deals; associates screen them. Write to the person whose portfolio is closest to yours.
  • Use a direct email. 5 of the 7 AstraZeneca profiles include a verified address, which beats a website form or a cold LinkedIn message.

AstraZeneca investors by country